Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.22 HKD | 0.00% | +1.67% | -14.08% |
25/03 | Zhongzhi Pharmaceutical's Attributable Jumps in 2023 | MT |
22/03 | Zhongzhi Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 13 June 2024 | CI |
Sales 2022 | 1.83B 252M 1.97B 21.01B | Sales 2023 | 2.05B 283M 2.21B 23.59B | Capitalization | 1.11B 154M 1.2B 12.83B |
---|---|---|---|---|---|
Net income 2022 | 106M 14.63M 115M 1.22B | Net income 2023 | 163M 22.5M 176M 1.88B | EV / Sales 2022 | 0.33 x |
Net cash position 2022 | 225M 31.03M 243M 2.59B | Net cash position 2023 | 17.45M 2.41M 18.85M 201M | EV / Sales 2023 | 0.54 x |
P/E ratio 2022 |
7.66
x | P/E ratio 2023 |
6.79
x | Employees | 2,643 |
Yield 2022 |
5.51% | Yield 2023 |
6.33% | Free-Float | 24.24% |
1 week | +1.67% | ||
Current month | +2.52% | ||
1 month | +2.52% | ||
3 months | -1.61% | ||
6 months | -3.17% | ||
Current year | -14.08% |
Managers | Title | Age | Since |
---|---|---|---|
Ying Feng Lai
CEO | Chief Executive Officer | 32 | 01/14/01 |
Zhi Tian Lai
FOU | Founder | 57 | 12/14/12 |
Ying Sheng Lai
DFI | Director of Finance/CFO | 31 | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kwun Wan Ng
BRD | Director/Board Member | 61 | 08/15/08 |
Zhi Tian Lai
FOU | Founder | 57 | 12/14/12 |
Li Xia Jiang
BRD | Director/Board Member | 60 | 24/09/24 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1.22 | 0.00% | 0 |
25/24/25 | 1.22 | 0.00% | 0 |
24/24/24 | 1.22 | 0.00% | 0 |
23/24/23 | 1.22 | 0.00% | 0 |
22/24/22 | 1.22 | +1.67% | 26,000 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 01:38 pm IST
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.08% | 135M | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- 3737 Stock